Ibnsina Pharma (CAI:ISPH) Other Operating Expense : E£1,267 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma Other Operating Expense?

Ibnsina Pharma's Other Operating Expense for the three months ended in Mar. 2024 was E£30 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was E£1,267 Mil.

Ibnsina Pharma's quarterly Other Operating Expense increased from Sep. 2023 (E£21 Mil) to Dec. 2023 (E£1,196 Mil) but then declined from Dec. 2023 (E£1,196 Mil) to Mar. 2024 (E£30 Mil).

Ibnsina Pharma's annual Other Operating Expense declined from Dec. 2021 (E£1,630 Mil) to Dec. 2022 (E£1,031 Mil) but then increased from Dec. 2022 (E£1,031 Mil) to Dec. 2023 (E£1,257 Mil).

Ibnsina Pharma Other Operating Expense Historical Data

The historical data trend for Ibnsina Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma Other Operating Expense Chart

Ibnsina Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

1,439.46

1,466.86

1,629.52

1,030.56

1,257.16

Ibnsina Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															19.96	19.96	20.98	1,196.26	29.78

Ibnsina Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£1,267 Mil.

Ibnsina Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibnsina Pharma (CAI:ISPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Industrial zone 1, PO box 91, Obour, EGY

Website

http://www.ibnsina-pharma.com

Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma (CAI:ISPH) Headlines

No Headlines